HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinicohistological study of oligodendroglioma and oligoastrocytoma.

Abstract
The clinical and histological characteristics of oligodendroglioma and oligoastrocytoma were investigated in patients, mainly adults with supratentorial tumors, who were treated with surgery and radiotherapy, and with chemotherapy for recurrent, anaplastic tumors, or both. The median survival time was 13.2 years for oligodendroglioma (four patients), 12.7 years for anaplastic oligodendroglioma (five patients), 13.5 years for oligoastrocytoma (seven patients), and 4.8 years for anaplastic oligoastrocytoma (four patients). Two of three recurrent oligodendrogliomas and two of two recurrent oligoastrocytomas showed malignant transformation. Minigemistocytes were sometimes recognized in recurrent tumors and had a sinister prognosis. Oligodendroglioma and oligoastrocytoma may transform into each other at recurrence.
AuthorsM Tamura, A Zama, H Kurihara, T Kano, H Imai, S Ishiuchi, T Iwai, I Naito
JournalBrain tumor pathology (Brain Tumor Pathol) Vol. 14 Issue 1 Pg. 35-9 ( 1997) ISSN: 1433-7398 [Print] Japan
PMID9384800 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Astrocytoma (mortality, pathology, therapy)
  • Brain Neoplasms (mortality, pathology, therapy)
  • Cell Transformation, Neoplastic (pathology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (pathology)
  • Oligodendroglioma (mortality, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: